- Home
- RKDA vs VRAX Comparison
RKDA vs VRAX Comparison
Compare RKDA & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RKDA | VRAX |
|---|---|---|
| Founded | 2002 | 2013 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9M | 1.7M |
| IPO Year | 2015 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RKDA | VRAX |
|---|---|---|
| Price | $1.07 | $0.21 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $1.00 |
| AVG Volume (30 Days) | 1.9M | ★ 32.6M |
| Earning Date | 05-07-2026 | 06-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 66.92 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $4,858,000.00 | N/A |
| Revenue This Year | $61.67 | $217,274.83 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.80 | $0.10 |
| 52 Week High | $6.71 | $1.14 |
Technical Indicators
Market Signals| Indicator | RKDA | VRAX |
|---|---|---|
| Relative Strength Index (RSI) | 47.18 | 48.41 |
| Support Level | $0.85 | $0.15 |
| Resistance Level | $1.51 | $0.24 |
| Average True Range (ATR) | 0.16 | 0.07 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 27.62 | 6.15 |
Price Performance
Historical ComparisonAbout RKDA Arcadia Biosciences Inc.
Arcadia Biosciences Inc is a company with science-based approaches to develop high value products and drive innovation in the consumer goods industry. The company has one operating and reportable segment, which derives revenue from the sale of Zola coconut water. The company's consumer brands in the food, beverage, and body care categories, and others. Its products include: Zola Coconut Water, and Agronomic Wheat Traits. Geographically, the company operates in United States, Argentina, India, and Canada. It derives maximum revenue from United States.
About VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is an inventive biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Through its ViraxImmune platform and ImmuneSelect portfolio of research-use-only (RUO) products and services, the Company is building an immune-profiling offering that spans RUO assays, preclinical immunology services and, longer term, T cell-based diagnostics aimed at post-acute infection syndromes (PAIS) such as Long COVID and other chronic conditions linked to immune dysregulation.